Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to the Editor
  • Published:

IL-6 release and airway administration of human CFTR cDNA adenovirus vector

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rosenfeld, M.A. et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143–155 (1992).

    Article  CAS  Google Scholar 

  2. Crystal, R.G. et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42–51 (1994).

    Article  CAS  Google Scholar 

  3. Crystal, R.G. Protocol for gene therapy of the respiratory manifestations of cystic fibrosis using a replication deficient recombinant adenovirus to transfer the normal cystic fibrosis transmembrane conductance regulator cDNA to the airway epithelium. Fed. Register 58, 21737–21738 (1992).

    Google Scholar 

  4. Brody, S.L., Metzger, M., Danel, C., Rosenfeld, M. & Crystal, R.G. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 821–836 (1994).

    Article  CAS  Google Scholar 

  5. Zabner, J. et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207–216 (1993).

    Article  CAS  Google Scholar 

  6. Wilson, J.M. Gene therapy of cystic fibrosis lung disease using El deleted adenovirus: a phase 1 trial. Fed. Register 58, 47906 (1993).

    Google Scholar 

  7. Boucher, R.C. & Knowles, M.R. Gene therapy for cystic fibrosis using El deleted adenovirus: a phase 1 trial in the nasal cavity. Fed. Register 58, 53814 (1993).

    Google Scholar 

  8. Wilmott, R.W., Whitsett, J. & Trapnell, B. A phase 1 study of gene therapy of cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. Fed. Register 58, 21739 (1993).

    Google Scholar 

  9. Van Snick, J., Interleukin-6: An overview. Annu. Rev. Immun. 8, 253–278 (1990).

    Article  CAS  Google Scholar 

  10. Weber, J. et al. Phase 1 trial of subcutaneous interleukin-6 in patients with advanced malignancies. J. clin. Oncol. 11, 499–506 (1993).

    Article  CAS  Google Scholar 

  11. McElvaney, N.G. et al. Modulation of airway inflammation in cystic fibrosis: in vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J. clin. Invest. 90, 1296–1301 (1992).

    Article  CAS  Google Scholar 

  12. Melani, C. et al. Interleukin-6 expression in human neutrophil and eosinophil periphera blood granulocytes. Blood 81, 2744–2749 (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McElvaney, N., Crystal, R. IL-6 release and airway administration of human CFTR cDNA adenovirus vector. Nat Med 1, 182–184 (1995). https://doi.org/10.1038/nm0395-182b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0395-182b

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing